President Donald Trump’s economic approval rating has fallen to the lowest point of either of his two terms, according to the latest CNBC All-America Economic Survey. Eight out of ten Americans now
The U.S. Equal Employment Opportunity Commission has proposed eliminating the EEO-1 report, a workforce demographics filing requirement that has been in place since 1966. The proposal, issued alongside a public meeting held
More
A social media video circulating online has set the legal world abuzz after viewers identified a Biglaw partner and associate making out on a public park bench. The video was originally posted
More
Bloom Energy (NYSE: BE) has attracted renewed investor interest alongside two other AI infrastructure plays, all highlighted for their robust cash flow generation in the current market environment. Cash flow strength has
More
The FTSE 100 index posted gains as oil prices retreated below the significant US$100 per barrel threshold, offering relief to markets sensitive to energy costs. Falling oil prices tend to ease inflationary
More
Cencora is restructuring its entire distribution strategy to keep pace with the rapid growth of specialty pharmaceuticals and cold chain medicine demand. Senior Vice President of Global Supply Chain Brent Wilhelm says
More
On 29 June 2026, the Supreme Court agreed to hear a trademark dispute between RiseandShine Corporation, trading as Rise Brewing, and PepsiCo, Inc. over Pepsi’s “Mtn Dew Rise Energy” drink. The Court
More
The Legal Marketing Association has published fresh guidance across four key areas reshaping how law firms approach marketing, business development, and operational structure. The insights come through Strategies and Voices, LMA’s official
More
Bank of America’s closely watched sell indicator for equities has climbed to its highest level since 2021, raising fresh concerns among market watchers about stretched valuations. The signal, which Bank of America
More
London’s FTSE 100 index pushed higher as banking giant HSBC provided a strong lift to financial stocks across the broader market. HSBC (HSBA), one of the world’s largest banks by assets, led
More
Ipsen has announced that its Bylvay drug has failed to meet the primary endpoint in a major Phase 3 clinical trial targeting biliary atresia in young children. The French pharmaceutical company revealed
More